Free Trial

ARS Pharmaceuticals (SPRY) Institutional Ownership

→ Elon Musk Secret Crypto Plot Exposed (From Crypto 101 Media) (Ad)
Free SPRY Stock Alerts
$9.06
-0.41 (-4.33%)
(As of 05/8/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for ARS Pharmaceuticals (NASDAQ:SPRY)

Current
Institutional Ownership
Percentage
68.16%
Number of
Institutional Buyers
(last 12 months)
35
Total
Institutional Inflows
(last 12 months)
$105.93M
Number of
Institutional Sellers
(last 12 months)
10
Total
Institutional Outflows
(last 12 months)
$32.67M
Get SPRY Insider Trade Alerts

Want to know when executives and insiders are buying or selling ARS Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

SPRY Institutional Buying and Selling by Quarter

ARS Pharmaceuticals Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/8/2024Russell Investments Group Ltd.5,897$60K0.0%N/A0.006%
5/7/2024ClariVest Asset Management LLC272,956$2.79M0.3%N/A0.282%
5/7/2024 SG Americas Securities LLC11,606$119K0.0%N/A0.012%
5/3/2024 GSA Capital Partners LLP128,889$1.32M0.1%+11.7%0.133%
5/1/2024 Capstone Investment Advisors LLC72,322$739K0.0%N/A0.075%
4/30/2024 J.W. Cole Advisors Inc.13,900$142K0.0%N/A0.014%
4/29/2024 FAS Wealth Partners Inc.60,470$618K0.1%+31.5%0.063%
4/29/2024 China Universal Asset Management Co. Ltd.18,453$189K0.0%+66.2%0.019%
2/14/2024Sectoral Asset Management Inc.354,641$1.94M0.8%-66.2%0.369%
2/13/2024Tower Research Capital LLC TRC7,065$39K0.0%-80.2%0.007%
2/9/2024Franklin Resources Inc.4,098,497$22.46M0.0%+5.9%4.269%
2/6/2024AJOVista LLC7,822$43K0.1%N/A0.008%
2/6/2024Levin Capital Strategies L.P.52,250$286K0.0%-61.0%0.054%
2/6/2024Swiss National Bank66,000$362K0.0%-19.8%0.069%
1/25/2024 Nisa Investment Advisors LLC5,600$31K0.0%+22,300.0%0.006%
1/24/2024 China Universal Asset Management Co. Ltd.11,105$61K0.0%+352.7%0.012%
1/19/2024 Denali Advisors LLC87,500$480K0.1%N/A0.091%
1/10/2024 Charles Schwab Trust Co3,996,071$21.90M2.2%-5.9%4.163%
11/15/2023Tejara Capital Ltd103,739$392K0.2%-22.3%0.108%
11/15/2023RA Capital Management L.P.9,459,678$35.76M0.7%+214.3%9.854%
11/15/2023Sectoral Asset Management Inc.1,049,191$3.97M0.8%-16.4%1.093%
11/14/2023Rubric Capital Management LP639,203$2.42M0.1%-77.2%0.666%
11/13/2023FMR LLC1,307,340$4.94M0.0%-72.0%1.362%
11/13/2023Tejara Capital Ltd103,739$392K0.3%-22.3%0.108%
11/9/2023Letko Brosseau & Associates Inc.36,000$136K0.0%N/A0.038%
11/8/2023 Janney Montgomery Scott LLC24,072$91K0.0%-39.8%0.025%
10/24/2023 Bank of New York Mellon Corp83,924$317K0.0%+9.1%0.088%
10/23/2023 FAS Wealth Partners Inc.45,970$174K0.0%+34.2%0.048%
10/20/2023 Charles Schwab Trust Co4,246,071$16.05M1.8%N/A4.443%
10/12/2023 Brendel Financial Advisors LLC19,125$72K0.1%N/A0.020%
10/11/2023Vontobel Holding Ltd.260,684$985K0.0%-24.2%0.273%
9/21/2023Barclays PLC20,460$138K0.0%N/A0.021%
8/14/2023Caption Management LLC73,400$492K0.0%N/A0.077%
8/11/2023Sectoral Asset Management Inc.1,255,640$8.41M1.4%N/A1.325%
8/11/2023Rubric Capital Management LP2,799,203$18.76M0.8%-19.6%2.954%
8/11/2023Tejara Capital Ltd133,521$895K0.4%N/A0.141%
8/10/2023Nicholas Investment Partners LP275,000$1.84M0.1%N/A0.290%
8/8/2023 FAS Wealth Partners Inc.34,250$229K0.0%N/A0.036%
8/7/2023Royce & Associates LP463,700$3.11M0.0%+52.6%0.489%
8/4/2023American International Group Inc.11,672$78K0.0%N/A0.012%
Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (Ad)

Are you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.

Don't miss out on the "next Ozempic" >>>
8/1/2023Arizona State Retirement System10,606$71K0.0%N/A0.011%
7/31/2023Levin Capital Strategies L.P.169,074$1.13M0.1%N/A0.178%
7/28/2023Shell Asset Management Co.65,322$438K0.0%N/A0.069%
7/26/2023 Janney Montgomery Scott LLC39,969$268K0.0%N/A0.042%
7/25/2023 DekaBank Deutsche Girozentrale35,000$231K0.0%N/A0.037%
7/24/2023Vontobel Holding Ltd.344,029$2.31M0.0%N/A0.363%
7/19/2023 Teacher Retirement System of Texas10,244$69K0.0%N/A0.011%
7/18/2023 Avantax Planning Partners Inc.32,174$216K0.0%N/A0.034%
6/1/2023Prelude Capital Management LLC15,053$98K0.0%N/A0.016%
5/23/2023Royce & Associates LP303,900$1.98M0.0%N/A0.321%
5/19/2023SR One Capital Management LP4,012,903$26.12M8.9%N/A4.234%
5/16/2023Baker BROS. Advisors LP2,006,451$13.06M0.1%N/A2.121%
(Data available from 1/1/2016 forward)

SPRY Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of SPRY shares?

During the previous two years, 39 institutional investors and hedge funds held shares of ARS Pharmaceuticals. The most heavily invested institutionals were RA Capital Management L.P. ($35.76M), SR One Capital Management LP ($26.12M), Franklin Resources Inc. ($22.46M), Charles Schwab Trust Co ($21.90M), Baker BROS. Advisors LP ($13.06M), FMR LLC ($4.94M), and Royce & Associates LP ($3.11M).Learn more on SPRY's institutional investors.

What percentage of ARS Pharmaceuticals stock is owned by institutional investors?

68.16% of ARS Pharmaceuticals stock is owned by institutional investors. Learn more on SPRY's institutional investor holdings.

Which institutional investors have been buying ARS Pharmaceuticals stock?

Of the 35 institutional investors that purchased ARS Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($6.45M), Charles Schwab Trust Co ($4.25M), SR One Capital Management LP ($4.01M), Baker BROS. Advisors LP ($2.01M), Sectoral Asset Management Inc. ($1.26M), Royce & Associates LP ($463.70K), and Vontobel Holding Ltd. ($344.03K).

How much institutional buying is happening at ARS Pharmaceuticals?

Institutional investors have bought a total of 20,530,019 shares in the last 24 months. This purchase volume represents approximately $105.93M in transactions.

Which ARS Pharmaceuticals major shareholders have been selling company stock?

Of the 10 institutional investors that sold ARS Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: FMR LLC ($3.36M), Rubric Capital Management LP ($2.84M), Sectoral Asset Management Inc. ($901.00K), Charles Schwab Trust Co ($250K), Vontobel Holding Ltd. ($83.35K), Levin Capital Strategies L.P. ($81.75K), and Tejara Capital Ltd ($59.56K).

How much institutional selling is happening at ARS Pharmaceuticals?

Institutional investors have sold a total of 7,635,383 shares in the last 24 months. This volume of shares sold represents approximately $32.67M in transactions.


Related Companies:
This page (NASDAQ:SPRY) was last updated on 5/8/2024 by MarketBeat.com Staff

From Our Partners
The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way
Smallcaps Daily
Tech GIANT’s Plans to Revolutionize Crypto…
Crypto 101 Media
AI “wealth window” is closing June 25th
Paradigm Press
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years
Banyan Hill Publishing
Charles Payne Demystifies Options
Unstoppable Prosperity
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
He Is Giving Away Bitcoin
Crypto Swap Profits
The AI Stock that’s Disrupting Every Industry
StockEarnings